Bioluminescence immunoassay for angiotensin II using aequorin as a label

Analytical Biochemistry

Volumn 371, Issue 2, 2007, Pages 154-161

  Qu, Xiaoge ^a   Deo, Sapna K ^a   Dikici, Emre ^a   Ensor, Mark ^a   Poon, Michael ^b   Daunert, Sylvia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aequorin; Angiotensin II; Bioluminescence immunoassay; Reporter protein

Indexed keywords

BIOLUMINESCENCE; BLOOD PRESSURE; CARDIOLOGY; DISEASES; MOLECULAR BIOLOGY; PHOSPHORESCENCE; PLASMA (HUMAN); PROTEINS;

ACTIVE COMPONENTS; AEQUORIN; ANGIOTENSIN II; ARTERIAL PRESSURES; HETEROGENEOUS IMMUNOASSAY; PHYSIOLOGICAL LEVELS; RENIN-ANGIOTENSIN SYSTEM; REPORTER PROTEIN;

IMMUNOLOGY;

AEQUORIN; ANGIOTENSIN II; HYBRID PROTEIN;

AMINO TERMINAL SEQUENCE; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BIOLUMINESCENCE; CARBOXY TERMINAL SEQUENCE; CHEMICAL LABELING; GENETIC ENGINEERING; HUMAN; IMMUNOASSAY; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EID: 35548977565     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.08.038     Document Type: Article

References (32)

1. Kostis J.B., and DeFelice E.A. Angiotensin converting enzyme inhibitors (1987), Alan R. Liss Inc., New York
2. Vallotton M.B. The renin-angiotensin system. Trends In Pharmacological Science 8 (1987) 69-74
3. Kim S., Ohta K., Hamaguchi A., Yukimura T., Miura K., and Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25 (1995) 1252-1259
4. Geisterfer A.A., Peach M.J., and Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circulation research 62 (1988) 749-756
5. Weir M.R., and Dzau V.J. The renin-angiotensin-aldosterone system: a specific target for hypertension management. American journal of hypertension 12 (1999) 205S-213S
6. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. The American journal of cardiology 89 (2002) 3A-9A discussion 10A
7. Nicholls M.G., Richards A.M., and Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease. Journal of human hypertension 12 (1998) 295-299
8. Paulson S., Verhage L., Mayer D., Miller K., and Schoenhard G. A nonequilibrium radioimmunoassay for angiotensin II. Journal of pharmacological and toxicological methods 32 (1994) 93-97
9. Lawrence A.C., Evin G., Kladis A., and Campbell D.J. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. Journal of hypertension 8 (1990) 715-724
10. Simon D., Romestand B., Huang H., Badouaille G., Fehrentz J.A., Pau B., Marchand J., and Corvol P. Direct, simplified, and sensitive assay of angiotensin II in plasma extracts performed with a high-affinity monoclonal antibody. Clinical chemistry 38 (1992) 1963-1967
11. Voelker J.R., Cobb S.L., and Bowsher R.R. Improved HPLC-radioimmunoassay for quantifying angiotensin II in plasma. Clinical chemistry 40 (1994) 1537-1543
12. Nussberger J., Brunner D.B., Waeber B., and Brunner H.R. Octapeptide-specific and sensitive assay for angiotensin II in plasma. International journal of environmental analytical chemistry 25 (1986) 257-268
13. Yasunaga F., Kawano A., Morikawa N., and Takeyama M. Enzyme immunoassay of angiotensin II in human plasma. Chemical & pharmaceutical bulletin 40 (1992) 792-794
14. Volland H., Pradelles P., Ronco P., Azizi M., Simon D., Creminon C., and Grassi J. A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. Journal of Immunological Methods 228 (1999) 37-47
15. Lacher N.A., Garrison K.E., and Lunte S.M. Separation and detection of angiotensin peptides by Cu(II) complexation and capillary electrophoresis with UV and electrochemical detection. Electrophoresis 23 (2002) 1577-1584
16. Sim M.K., and Qui X.S. Angiotensins in plasma of hypertensive rats and human. Regulatory peptides 111 (2003) 179-182
17. Deo S.K., and Daunert S. Luminescent proteins from Aequorea victoria: applications in drug discovery and in high throughput analysis. Fresenius J. Anal. Chem. 369 (2001) 258-266
18. Ohmiya Y., and Hirano T. Shining the light: The mechanism of the bioluminescence reaction of calcium-binding photoproteins. Chem. Biol. 3 (1996) 337-347
19. Ramanathan S., Lewis J.C., Kindy M.S., and Daunert S. Heterogeneous bioluminescence binding assay for an octapeptide using recombinant aequorin. Analytica Chimica Acta 369 (1998) 181-188
20. De Giorgi F., Brini M., Bastianutto C., Marsault R., Montero M., Pizzo P., Rossi R., and Rizzuto R. Targeting aequorin and green fluorescent protein to intracellular organelles. Gene 173 (1996) 113-117
21. Brini M., Pinton P., Pozzan T., and Rizzuto R. Targeted recombinant aequorins: tools for monitoring [Ca2+] in the various compartments of a living cell. Microsc. Res. Tech. 46 (1999) 380-389
22. S. Ramanathan, A. Witkowski, and S. Daunert, A Bioluminescence Binding Assay for Biotin with Attomole Detection Based on Recombinant Aequorin, Abstracts of Papers of the American Chemical Society 207 (1994) 52-Anyl.
23. Huang W., Feltus A., Witkowski A., and Daunert S. Homogeneous bioluminescence competitive binding assay for folate based on a coupled glucose-6-phosphate dehydrogenase--bacterial luciferase enzyme system. Anal. Chem. 68 (1996) 1646-1650
24. Lewis J.C., and Daunert S. Bioluminescence immunoassay for thyroxine employing genetically engineered mutant aequorins containing unique cysteine residues. Anal. Chem. 73 (2001) 3227-3233
25. Deo S.K., and Daunert S. An immunoassay for Leu-enkephalin based on a C-terminal aequorin-peptide fusion. Anal. Chem. 73 (2001) 1903-1908
26. Desai U.A., Deo S.K., Hyland K.V., Poon M., and Daunert S. Determination of prostacyclin in plasma through a bioluminescent immunoassay for 6-keto-prostaglandin F1alpha: implication of dosage in patients with primary pulmonary hypertension. Anal. Chem. 74 (2002) 3892-3898
27. Mirasoli M., Deo S.K., Lewis J.C., Roda A., and Daunert S. Bioluminescence immunoassay for cortisol using recombinant aequorin as a label. Anal. Biochem. 306 (2002) 204-211
28. Nomura M., Inouye S., Ohmiya Y., and Tsuji F.I. A C-terminal proline is required for bioluminescence of the Ca(2+)-binding photoprotein, aequorin. FEBS Lett. 295 (1991) 63-66
29. Lewis J.C., Lopez-Moya J.J., and Daunert S. Bioluminescence and secondary structure properties of aequorin mutants produced for site-specific conjugation and immobilization. Bioconjug. Chem. 11 (2000) 65-70
30. Kurose K., Inouye S., Sakaki Y., and Tsuji F.I. Bioluminescence of the Ca2+binding photoprotein aequorin after cysteine modification. Proc. Natl. Acad. Sci. USA 86 (1989) 80-84
31. Mento P.F., and Wilkes B.M. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 9 (1987) III42-III48
32. Matsui T., Tamaya K., Kawasaki T., and Osajima Y. Determination of angiotensin metabolites in human plasma by fluorimetric high-performance liquid chromatography using a heart-cut column-switching technique. Journal of Chromatography 729 (1999) 89-95